Archive · 18 Jul 2025
More Substandard and Spurious Drugs Found in India in June
In June, government labs tested medicines and found that some weren't good enough, meaning they were not up to standard.
Central labs found 55 such samples, while state labs found 130.
Also, some fake drugs were found in a few places.
These fake drugs were made by people who weren't supposed to make them.
The government works with local authorities to make sure these bad medicines are taken off the shelves and to keep people safe.
Central drug labs found 55 drug samples to be 'not of standard quality' in June.
State drug testing laboratories identified 130 drug samples as 'not of standard quality' in June.
One drug sample each from Bihar and Delhi, and two from Telangana, were identified as spurious.
Spurious drugs were manufactured by an unauthorized entity.
Action is taken with state regulators to remove substandard drugs from the market.
- Who
- Central Drugs Laboratories and state drug testing laboratories.
- What
- Central and state drug testing laboratories identified drug samples that were not of standard quality and spurious drugs.
- When
- June 2025
- Where
- India; spurious drugs found in Bihar, Delhi, and Telangana.
- Why
- To ensure drug integrity and patient safety.
Manufacturer Accountability
Government Response
Quality Control
Manufacturer Accountability
Manufacturers should ensure drug quality.
Government Response
The government is working to identify and remove substandard drugs.
- NSQ Drug Samples (Central Labs)
- 55
- NSQ Drug Samples (State Labs)
- 130
- Spurious Drug Locations
- Bihar, Delhi, Telangana
- Regulatory Bodies
- Central and State Drug Labs
- Government Action
- Identifying and removing substandard drugs
